Mycophenolate mofetil in the treatment of lupus nephritis
Patrick FK Yong1,2, David P D’Cruz21Department of Clinical Immunology, Kings College Hospital; 2The Lupus Research Unit, St Thomas’ Hospital, London, UKAbstract: Lupus nephritis is a complication of systemic lupus erythematosus, which has significant morbidity and mortali...
Guardado en:
Autores principales: | Patrick FK Yong, David P D’Cruz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c286db1b05d497ea6a619416308f8e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal A, et al.
Publicado: (2020) -
Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
por: Farhad Handjani, et al.
Publicado: (2017) -
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
por: Snigdha Nutalapati, et al.
Publicado: (2021) -
Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
por: Chad Heatwole, et al.
Publicado: (2008) -
Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Oh Chan Kwon, et al.
Publicado: (2021)